MING MEDICAL SERVICES
Giving hope, where there is none
Hosp
CANCER RESEARCH

Cord Blood NK Cell

Development Of New Human Cord Blood Derived Natural Killer Cell For Cancer Immunotherapy And Anti-Tumour Efficacy

Phase 1
Establishing human umbilical cord blood Natural Killer Cell (hUCB-NK)

Phase 2

  • Characterization of NK Cell
  • In Vitro cytotoxicity as-say

Phase 3
Pre-clinical trial in Diabetic rat model

Phase 4
Human clinical trial phase l & ll

New Research
  • cGMP condition developed human umbilical cord blood Natural Killer Cell (hUCB-NK)
  • Novel cell-based treatment for various cancer types:
    1. Lung cancer
    2. Leukaemia
    3. Nasopharygeal Cancer (NPC)
    4. Breast Cancer
    5. Pancreatic Cancer

Conducted By:


Copyright 2011-2020 Ming Medical Services. All Rights Reserved